- Tumors1000+
- Pathologic Processes1000+
- Nervous System Diseases988
- Pathology914
- Cancer874
Any
<10 miles
<30 miles
<50 miles
<70 miles
Filter Results
Condition
- Tumors1000+
- Pathologic Processes1000+
- Nervous System Diseases988
- Pathology914
- Cancer874
Where are you looking?
How far are you willing to travel?Any
How old are you?
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
- HER2 negative
- PD-L1 positive
- ER positive
- HER2 positive
- EGFR positive
- PD-L1 negative
- PR positive
- EGFR negative
- KRAS positive
- ALK negative
- BRAF positive
- ER negative
- PR negative
- CD20 positive
- ALK positive
- BRCA1 positive
- BRAF negative
- IDH positive
- BRCA2 positive
- ROS1 negative
- p16 positive
- HLA positive
- MYC positive
- PIK3CA positive
- RET positive
- ROS1 positive
- CD19 positive
- HLA-A positive
- HR positive
- MET positive
- TP53 positive
- dMMR positive
- IDH negative
- BCL2 positive
- MSI-H positive
- NF1 positive
- p16 negative
- ANA positive
- BCL6 positive
- KRAS negative
- MET negative
- NRAS positive
- NTRK positive
- PALB2 positive
- anti-dsDNA positive
- HBsAg positive
- HPV negative
- HPV positive
- MSS positive
- RAS positive
- RET negative
- TP53 negative
- BCR-ABL1 positive
- BRCA1 negative
- CFTR positive
- ctDNA positive
- pMMR positive
- ABCA4 positive
- BRCA2 negative
- CCND1 positive
- Ex19del positive
- FGFR2 positive
- L858R positive
- NTRK negative
- PTEN positive
- RAS negative
- RB1 positive
- TTR positive
- anti-Sm positive
- BRCA positive
- CD123 positive
- CD5 positive
- CLDN18.2 positive
- COL7A1 positive
- DMD positive
- HLA negative
- HLA-A negative
- MDM2 positive
- MGMT negative
- MMR negative
- RB1 negative
- T790M positive
- TROP2 negative
- TROP2 positive
- AKT negative
- APP positive
- C5 positive
- CD30 positive
- DLL3 positive
- EBV positive
- ER/PR positive
- FLT3 positive
- FMR1 positive
- HBV DNA negative
- HR negative
- HRAS positive
- MGMT positive
- MMR positive
- MSI-H negative
- NRAS negative
- PSEN1 positive
- PSEN2 positive
- PTCH1 positive
- Philadelphia chromosome negative
- Philadelphia chromosome positive
- PiZZ positive
- RF positive
- RHO positive
- SMARCA4 positive
- dMMR negative
- t(11;14) positive
- β-thalassemia positive
- 11q negative
- 11q positive
- AKT positive
- ALPL positive
- ALT positive
- APOL1 positive
- ARID1A positive
- ATM positive
- Anti-PLA2R positive
- Aβ1-42 positive
- B7-H3 positive
- CAG repeat in HTT positive
- CD23 positive
- CDK4 positive
- CEACAM5 positive
- COL1A1 positive
- COL1A2 positive
- EBV DNA positive
- ER or PR positive
- FGFR3 positive
- FLT3 negative
- FOXO1 fusion negative
- FVIII positive
- G719X positive
- GBA positive
- GPC3 positive
- GRN positive
- HBB positive
- HBcAb negative
- HBcAb positive
- HBsAg negative
- HEXA positive
- HEXB positive
- HPV16 positive
- HRD positive
- HbE positive
- HbSS positive
- IGHV negative
- IGHV positive
- JAK2 positive
- KIT positive
- L861Q positive
- MLH1 positive
- MSH2 positive
- MSH6 positive
- MSS negative
- MUC1 positive
- MYC negative
- NF2 positive
- NPM1 positive
- NTRK1 positive
- NY-ESO-1 positive
- PDE6A positive
- PDE6B positive
- PIK3CA negative
- PIK3CD positive
- PIK3R1 positive
- PKLR positive
- PMM2 positive
- PMS2 positive
- PTEN negative
- Ph positive
- RAF positive
- S768I positive
- SMARCB1 negative
- SMN1 positive
- SPINK5 positive
- TET2 positive
- TTR negative
- UBA1 positive
- UGT1A1 positive
- anti-AChR positive
- anti-MuSK positive
- anti-Ro autoantibodies positive
- anti-Ro/SSA positive
- anti-Smith positive
- del(17p) negative
- other sickle cell syndrome variants positive
- p53 positive
- 11q del negative
- 12 negative
- 12 positive
- 13q del negative
- 13q negative
- 13q positive
- 16p11.2 deletion positive
- 17p negative
- 17p positive
- Gleason Score 10
- Gleason Score 6
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1927nm Fractional Thulium Laser Treatment
- Adjuvant Therapy (except reconstruction)
- Anti-HER2 Therapy
- Anti-Seizure Medications (up to 2 types)
- Any Treatment for Pancreatic Cancer
- At least one prior tumor-directed therapy
- Avoidance of Activities That Cause Joint Pain
- Beovu
- Biologic Anti-Neoplastic Agent
- Branch Retinal Vein Occlusion (BRVO)
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
6622 trials
1
2
3
…50